UBS Group’s ZELTIQ Aesthetics, Inc. ZLTQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-164,675
Closed -$9.16M 8373
2017
Q1
$9.16M Buy
164,675
+155,935
+1,784% +$7.82M 0.01% 1582
2016
Q4
$380K Sell
8,740
-3,086
-26% -$124K ﹤0.01% 4318
2016
Q3
$464K Buy
11,826
+2,809
+31% +$100K ﹤0.01% 3964
2016
Q2
$246K Buy
9,017
+4,526
+101% +$127K ﹤0.01% 4416
2016
Q1
$122K Buy
4,491
+152
+4% +$3.58K ﹤0.01% 4834
2015
Q4
$123K Buy
4,339
+2,276
+110% +$71.9K ﹤0.01% 5054
2015
Q3
$66K Sell
2,063
-1,022
-33% -$33.8K ﹤0.01% 5578
2015
Q2
$91K Sell
3,085
-37,500
-92% -$1.13M ﹤0.01% 5479
2015
Q1
$1.25M Sell
40,585
-38,846
-49% -$1.24M ﹤0.01% 3366
2014
Q4
$2.22M Buy
+79,431
New +$2.07M ﹤0.01% 2809

Other funds holding ZLTQ

UBS Group's ZLTQ Position: Q2 2017 in Review

UBS Group sold out of ZELTIQ Aesthetics, Inc. (ZLTQ) in Q2 2017, closing a stake of 164,675 shares — an estimated $9.16M sold.

UBS Group first reported a position in ZLTQ in Q4 2014 and held it in 10 quarters. The position peaked at $9.16M in Q1 2017. 2 funds tracked by Wall St. Rank hold ZLTQ as of Q2 2017.

  • UBS Group reported no remaining ZELTIQ Aesthetics, Inc. position as of Q2 2017 after selling out during the quarter.
  • UBS Group sold 164,675 ZELTIQ Aesthetics, Inc. shares in Q2 2017, an estimated $9.16M.
  • UBS Group first reported a position in ZELTIQ Aesthetics, Inc. in Q4 2014 and held it in 10 quarters.
  • UBS Group's ZELTIQ Aesthetics, Inc. position peaked at $9.16M in Q1 2017.
  • 2 funds tracked by Wall St. Rank held ZELTIQ Aesthetics, Inc. as of Q2 2017.

Based on UBS Group's 13F filing for Q2 2017, filed 14 Aug 2017.